Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns for Rheumatoid Arthritis Among United States Physicians

被引：0
|
作者：
Emma Sullivan
Jim Kershaw
Stuart Blackburn
Jeannie Choi
Jeffrey R. Curtis
Susan Boklage
机构：
[1] Adelphi Real World,
[2] Sanofi,undefined
[3] University of Alabama at Birmingham,undefined
[4] Regeneron Pharmaceuticals,undefined
[5] Inc.,undefined
来源：
Rheumatology and Therapy | 2020年 / 7卷
关键词：
Biologic disease-modifying antirheumatic drugs; Cycling; Rheumatoid arthritis; Switching; Tumor necrosis factor inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：383 / 400
页数：17
相关论文
共 50 条
  • [1] Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns for Rheumatoid Arthritis Among United States Physicians
    Sullivan, Emma
    Kershaw, Jim
    Blackburn, Stuart
    Choi, Jeannie
    Curtis, Jeffrey R.
    Boklage, Susan
    [J]. RHEUMATOLOGY AND THERAPY, 2020, 7 (02) : 383 - 400
  • [2] Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns Among Rheumatologists in Europe and Japan
    Sullivan, Emma
    Kershaw, Jim
    Blackburn, Stuart
    Mahajan, Puneet
    Boklage, Susan H.
    [J]. RHEUMATOLOGY AND THERAPY, 2020, 7 (03) : 517 - 535
  • [3] Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns Among Rheumatologists in Europe and Japan
    Emma Sullivan
    Jim Kershaw
    Stuart Blackburn
    Puneet Mahajan
    Susan H. Boklage
    [J]. Rheumatology and Therapy, 2020, 7 : 517 - 535
  • [4] Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis
    Emery, Paul
    Sebba, Anthony
    Huizinga, Tom W. J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (12) : 1897 - 1904
  • [5] The economic burden of biologic disease-modifying antirheumatic drugs in rheumatoid arthritis patients in the United States
    Ding, Qian
    Shiltz, Dane
    Hossami, Dana
    Konieczny, Alison M.
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (08) : 1231 - 1241
  • [6] Patterns of biologic and targeted-synthetic disease-modifying antirheumatic drug use in rheumatoid arthritis in Australia
    Fletcher, Ashley
    Lassere, Marissa
    March, Lyn
    Hill, Catherine
    Barrett, Claire
    Carroll, Graeme
    Buchbinder, Rachelle
    [J]. RHEUMATOLOGY, 2022, 61 (10) : 3939 - 3951
  • [7] IMPACT OF CORTICOSTEROID UTILIZATION ON BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG INITIATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS
    Spivey, C. A.
    Griffith, J.
    Kaplan, C.
    Postlethwaite, A.
    Ganguli, A.
    Wang, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1503 - 1503
  • [8] Disease-modifying antirheumatic drug prescription patterns in adult rheumatoid arthritis patients in routine clinical practice in Spain
    Hernandez Cruz, Blanca
    Urena Garnica, Inmaculada
    Sanchez Parera, Ricardo
    Rubio Romero, Esteban
    Calvo Gutierrez, Jerusalen
    Garcia Sanchez, Antonio
    Rodriguez Escalera, Carlos
    Navarro Sarabia, Federico
    [J]. EUROPEAN JOURNAL OF RHEUMATOLOGY, 2020, 7 (04) : 149 - 157
  • [9] BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS PRESCRIPTION OVER TIME IN A COHORT OF EARLY RHEUMATOID ARTHRITIS PATIENTS
    Fedele, A. L.
    Melpignano, F.
    Bruno, D.
    La Ferrara, R.
    D'agostino, M. A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 603 - 603
  • [10] Disease-Modifying Antirheumatic Drug Initiation Among Patients Newly Diagnosed With Rheumatoid Arthritis
    Bonafede, Machaon
    Johnson, Barbara H.
    Shah, Neel
    Harrison, David J.
    Tang, Derek
    Stolshek, Bradley S.
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2018, 24 (08): : SP279 - +
12345